|
Indian Pharma Market registers 9.6% growth in October 2020
|
|
Yash Ved, Mumbai
November 10 , 2020
|
|
|
The Indian Pharmaceutical Market (IPM) has registered a growth of 9.6 per cent for the month of October 2020, after growing at 4.5 per cent in September.
According to AIOCD AWACS report, the IPM has recorded sales of Rs. 1,43,999 crore for moving annual total (MAT) basis during October 2020. Amongst the top 10 corporates, Mankind exhibited the highest growth of 8.6 per cent, followed by Torrent Pharma at 7.9 per cent.
Amongst the 11 to 25 ranked corporates, Himalaya exhibited highest growth of 14.8 per cent followed by Glenmark Pharmaceuticals at 16.6 per cent. Amongst the 26 to 50 ranked corporates, Boehringer Ingelheim registered the highest growth of 19.9 per cent followed by Medley at 15.6 per cent. Amongst the 51 to 75 ranked corporates, Danone registered the highest growth of 31.2 per cent.
Amongst the 76 to 100 ranked corporates, Reckitt Benckiser exhibited the highest growth at 29 per cent, followed by Llyod Hc at 20 per cent.
Cardiac registered a monthly growth of 19.5% in October as compared to 17.1% in September 2020, while anti-diabetic registered growth of 9.7% compared to 6.5% in September 2020. The respiratory medicines showed marginal improvement and are -6.6% in October 2020 as compared to -10.5% in September 2020.
Post unlockdown since June 2020, the struggle for anti-infectives 1.4% in September 2020 continues positive trend 6.6% in October 2020.
Associated therapy like gastro exhibits growth of 13.6% in October 2020 as against 5.5% in September 2020, while vitamins have bounced back has growth of 22.6% in October as against 16.3% September 2020.
The pain and analgesics are at 2.8% in October 2020 as against -4.3% in September 2020.
The NLEM 2013 containing molecules market showed growth at 4 per cent, whereas the non NLEM market registered growth of 3.9 per cent.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|